Chinese Journal of Pharmaceuticals
|
2022, 53(1): 134-139
• Pharmaceutical Management & Information •
Risk Analysis and Regulatory Considerations on Resuming Production of Long-term Unproduced Drugs under the New Situation
Full
Yuanyuan GE
, Juan ZHU
*, Jingchen ZHANG
Affiliations
- Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203
Published: 2022-01-10
doi: 10.16522/j.cnki.cjph.2022.01.016
Outline
葛渊源, 朱娟, 张景辰.
新形势下长期未生产药品恢复生产的风险分析与监管考量.
中国医药工业杂志,
2022
, 53
(1)
: 134
-139
.
DOI: 10.16522/j.cnki.cjph.2022.01.016
Yuanyuan GE, Juan ZHU, Jingchen ZHANG.
Risk Analysis and Regulatory Considerations on Resuming Production of Long-term Unproduced Drugs under the New Situation[J].
Chinese Journal of Pharmaceuticals,
2022
, 53
(1)
: 134
-139
.
DOI: 10.16522/j.cnki.cjph.2022.01.016
Year 2022 volume 53 Issue 1
72
15
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2022.01.016
- Receive Date:2021-10-26
- Online Date:2026-11-12
- Published:2022-01-10